Original Research
Published on 13 Sep 2024
Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1459909
- 593 views
Type at least 3 characters
2,250 articles
Articles
Review
Published on 13 Sep 2024
The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis – a review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1450493
- 971 views
Mini Review
Published on 12 Sep 2024
Flavonoids as therapeutic agents for epilepsy: unveiling anti-inflammatory and antioxidant pathways for novel treatments
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1457284
- 923 views
Review
Published on 11 Sep 2024
Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1403147
- 1,415 views
Editorial
Published on 11 Sep 2024
Editorial: Pharmacological actions of drugs in the brain: exploring the intricacies and potential therapeutic applications
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1486719
- 348 views
Original Research
Published on 11 Sep 2024
Isoliquiritigenin ameliorates abnormal oligodendrocyte development and behavior disorders induced by white matter injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1473019
- 735 views
Systematic Review
Published on 06 Sep 2024
Effect of N-acetylcysteine on craving in substance use disorders (SUD): a meta-analysis of randomized controlled trials
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1462612
- 1,197 views
Original Research
Published on 06 Sep 2024
The role of 5-HTergic neuron activation in the rapid antidepressant-like effects of hypidone hydrochloride (YL-0919) in mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1428485
- 641 views
Original Research
Published on 04 Sep 2024
Polydatin ameliorates early brain injury after subarachnoid hemorrhage through up-regulating SIRT1 to suppress endoplasmic reticulum stress
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1450238
- 927 views
Case Report
Published on 04 Sep 2024
Case report: Therapeutic drug monitoring and CYP2D6 phenoconversion in a protracted paroxetine intoxication
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1444857
- 769 views
- 1 citation
Original Research
Published on 04 Sep 2024
Liquiritin ameliorates painful diabetic neuropathy in SD rats by inhibiting NLRP3-MMP-9-mediated reversal of aquaporin-4 polarity in the glymphatic system
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1436146
- 907 views
Original Research
Published on 03 Sep 2024
Activation of EphrinB2/EphB2 signaling in the spine cord alters glia-neuron interactions in mice with visceral hyperalgesia following maternal separation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1463339
- 643 views
Original Research
Published on 30 Aug 2024
HLH-30/TFEB modulates autophagy to improve proteostasis in Aβ transgenic Caenorhabditis elegans
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433030
- 1,120 views
Original Research
Published on 30 Aug 2024
Efficacy and safety of Ginkgolide with intravenous alteplase thrombolysis in acute ischemic stroke with large vessel occlusion: a subgroup analysis of GIANT
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1452174
- 562 views
Mini Review
Published on 29 Aug 2024
Sex differences in opioid response: a role for the gut microbiome?
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1455416
- 747 views
Correction
Published on 29 Aug 2024
Corrigendum: Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1464358
- 516 views